Part of the Federation of State Medical Boards. Focuses on development of the model policy for the use of controlled substances for the treatment of pain.
Pain Policy Resource Center
Related posts
The End of an Absolute: Jehovah’s Witnesses Reconsider Blood Product TransfusionsBlood Products
The September 18th, 2026, announcement from the Governing Body of Jehovah’s Witnesses (JW) is one of the most consequential changes to the religion’s medical doctrine in modern times. For decades, JWs were told to refuse transfusion of blood and its four principal components (red cells, white cells, plasma, and platelets). That’s no longer the case. […]
Does the fitness industry pose a problem to our health?
Earlier this month at a Hyrox competition in Beijing, China, Australian athlete Joanna Wietrzyk soiled herself … and continued competing. As a result of her decision to not leave the course, her fellow competitors found themselves exposed to her waste. The photos went viral. People from across the globe weighed in. Eventually came online abuse […]
How “America First” Abandoned Global Health: The Case for an African Model
This editorial appears in the September Issue of the American Journal of Bioethics The COVID-19 pandemic has been called “an illustration par excellence of globalization”. Today, the world is witnessing another global health crisis. This time, the source is not a virus, but rather the current U.S. government’s “America First Global Health Strategy”. Like the pandemic, America […]
AI Use in Dementia Care Requires Engagement with Patient and Caregiver Perspectives
This editorial appears in the September Issue of the American Journal of Bioethics Liougas et al.’s composite case study analysis of real-time location systems for dementia care in a residential care home setting highlights the ethical problems that follow when a technical system is introduced without a clear and collectively shared purpose. Despite the growing consensus […]